1.01
price up icon3.81%   0.0371
after-market アフターアワーズ: 1.01
loading
前日終値:
$0.9729
開ける:
$0.9677
24時間の取引高:
1.66M
Relative Volume:
1.01
時価総額:
$116.48M
収益:
$13.45M
当期純損益:
$-178.23M
株価収益率:
-0.6121
EPS:
-1.65
ネットキャッシュフロー:
$-132.53M
1週間 パフォーマンス:
-2.88%
1か月 パフォーマンス:
-6.48%
6か月 パフォーマンス:
+11.59%
1年 パフォーマンス:
-71.55%
1日の値動き範囲:
Value
$0.9603
$1.01
1週間の範囲:
Value
$0.95
$1.0791
52週間の値動き範囲:
Value
$0.6611
$4.20

Fate Therapeutics Inc Stock (FATE) Company Profile

Name
名前
Fate Therapeutics Inc
Name
セクター
Healthcare (1149)
Name
電話
858.875.1803
Name
住所
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA
Name
職員
181
Name
Twitter
@fatethx
Name
次回の収益日
2025-08-08
Name
最新のSEC提出書
Name
FATE's Discussions on Twitter

FATE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FATE
Fate Therapeutics Inc
1.01 112.20M 13.45M -178.23M -132.53M -1.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Fate Therapeutics Inc Stock (FATE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 アップグレード BofA Securities Underperform → Neutral
2024-06-17 アップグレード Piper Sandler Neutral → Overweight
2023-03-27 再開されました Wells Fargo Equal Weight
2023-01-24 ダウングレード H.C. Wainwright Buy → Neutral
2023-01-06 ダウングレード BMO Capital Markets Outperform → Market Perform
2023-01-06 ダウングレード BofA Securities Buy → Underperform
2023-01-06 ダウングレード Cowen Outperform → Market Perform
2023-01-06 ダウングレード Piper Sandler Overweight → Neutral
2023-01-06 ダウングレード Stifel Buy → Hold
2023-01-06 ダウングレード Truist Buy → Hold
2023-01-06 ダウングレード Wedbush Outperform → Neutral
2023-01-03 ダウングレード Guggenheim Buy → Neutral
2022-12-22 ダウングレード Oppenheimer Outperform → Perform
2022-12-15 開始されました Goldman Sell
2022-11-04 再開されました Cantor Fitzgerald Overweight
2022-10-10 開始されました Canaccord Genuity Buy
2022-08-18 再開されました Wells Fargo Overweight
2022-07-28 開始されました Needham Hold
2022-07-11 アップグレード BMO Capital Markets Market Perform → Outperform
2022-06-03 開始されました Robert W. Baird Neutral
2022-02-11 再開されました BMO Capital Markets Market Perform
2021-12-15 アップグレード Wedbush Neutral → Outperform
2021-12-07 開始されました Cowen Outperform
2021-11-09 アップグレード Citigroup Neutral → Buy
2021-08-26 開始されました Morgan Stanley Equal-Weight
2021-06-07 アップグレード H.C. Wainwright Neutral → Buy
2021-05-07 アップグレード Wedbush Neutral → Outperform
2021-04-26 再開されました Jefferies Buy
2021-02-26 開始されました BofA Securities Buy
2021-02-26 ダウングレード Wedbush Outperform → Neutral
2021-02-11 ダウングレード Citigroup Buy → Neutral
2021-01-27 再開されました H.C. Wainwright Neutral
2020-05-13 開始されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-09 ダウングレード BMO Capital Markets Outperform → Market Perform
2019-12-30 繰り返されました Mizuho Buy
2019-12-09 アップグレード Wells Fargo Market Perform → Outperform
2019-11-12 開始されました SunTrust Buy
2019-11-06 ダウングレード Wells Fargo Outperform → Market Perform
2019-10-01 開始されました Stifel Buy
2019-08-09 開始されました BTIG Research Buy
2019-07-22 開始されました Cantor Fitzgerald Overweight
2019-07-12 開始されました Oppenheimer Outperform
2019-06-13 開始されました Mizuho Buy
2019-06-07 開始されました ROTH Capital Neutral
2019-05-31 開始されました Guggenheim Buy
2019-05-24 再開されました Citigroup Buy
2019-03-28 開始されました SVB Leerink Outperform
2019-01-03 ダウングレード Stephens Overweight → Equal-Weight
2018-11-05 開始されました Jefferies Buy
2018-08-01 開始されました Citigroup Buy
2018-03-06 ダウングレード H.C. Wainwright Buy → Neutral
すべてを表示

Fate Therapeutics Inc (FATE) 最新ニュース

pulisher
Sep 06, 2025

Price Floor Holding on Fate Therapeutics Inc. — Rebound PossibleJuly 2025 Summary & Verified Short-Term Trading Plans - beatles.ru

Sep 06, 2025
pulisher
Sep 06, 2025

Using data models to predict Fate Therapeutics Inc. stock movementEarnings Recap Summary & Consistent Return Investment Signals - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

Volume spikes in Fate Therapeutics Inc. stock – what they meanGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Heatmap analysis for Fate Therapeutics Inc. and competitorsJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Visual trend scoring systems applied to Fate Therapeutics Inc.Market Trend Report & AI Optimized Trading Strategy Guides - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What MACD and RSI say about Fate Therapeutics Inc.July 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Layoff Tracker: AC Immune To Cut 30% of Workforce - biospace.com

Sep 05, 2025
pulisher
Sep 05, 2025

Can technical indicators confirm Fate Therapeutics Inc.’s reversalSwing Trade & Stock Market Timing Techniques - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What are analysts’ price targets for Fate Therapeutics Inc.2025 Market Overview & Smart Swing Trading Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 04, 2025

Key metrics from Fate Therapeutics Inc.’s quarterly dataEarnings Recap Summary & Safe Investment Capital Preservation Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Does Fate Therapeutics Inc. show high probability of rebound2025 Geopolitical Influence & High Accuracy Investment Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Detecting support and resistance levels for Fate Therapeutics Inc.Weekly Stock Recap & Target Return Focused Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can volume confirm reversal in Fate Therapeutics Inc.2025 Fundamental Recap & Technical Buy Zone Confirmation - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Institutional scanner results for Fate Therapeutics Inc.Trade Volume Summary & Growth Focused Entry Point Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Fate Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Weekly High Conviction Trade Ideas - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is Fate Therapeutics Inc. trending in predictive chart modelsWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast Fate Therapeutics Inc. recoveryPrice Action & Stock Market Timing Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Fate Therapeutics' Equity Incentive Strategy and Its Implications for Talent Retention and Long-Term Value Creation - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Fate Therapeutics shares rise 3% after-hours following new employee inducement grants. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Is Fate Therapeutics Inc. stock entering bullish territoryTrade Exit Summary & Weekly High Potential Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Leerink Partners lowers Fate Therapeutics stock price target to $7 on iPSC CAR’iT pivot - Investing.com Canada

Sep 03, 2025
pulisher
Sep 03, 2025

Does Fate Therapeutics Inc. align with a passive investing strategyInflation Watch & Consistent Income Trade Recommendations - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

What are Fate Therapeutics Inc.’s recent SEC filings showingQuarterly Profit Review & Breakout Confirmation Trade Signals - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Why Fate Therapeutics Inc. stock attracts strong analyst attentionTrade Analysis Summary & Short-Term Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 09:36:15 - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Has Fate Therapeutics Inc. found a price floorWall Street Watch & Risk Managed Trade Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Fate Therapeutics Inc. stock hit new highs in YEARGap Down & Verified Swing Trading Watchlist - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Chart overlay techniques for tracking Fate Therapeutics Inc.2025 Technical Patterns & Entry and Exit Point Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Building trade automation scripts for Fate Therapeutics Inc.M&A Rumor & Low Risk Entry Point Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Abeona Therapeutics Inc. attractive at current valuationTrade Performance Summary & Community Trade Idea Sharing - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Backtesting results for Fate Therapeutics Inc. trading strategiesMarket Trend Review & Smart Allocation Stock Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Market reaction to Fate Therapeutics Inc.’s recent newsJuly 2025 Recap & High Accuracy Investment Entry Signals - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What is Fate Therapeutics Inc. s 5 year growth outlookTrade Volume Report & Weekly Breakout Stock Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Is Fate Therapeutics Inc. forming a bottoming baseJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Fate Therapeutics Inc. Crosses 200 Day MA — Signal or Noise getLinesFromResByArray error: size == 0 - 강소기업뉴스

Sep 01, 2025
pulisher
Sep 01, 2025

Will Fate Therapeutics Inc. stock go up soon2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Comparing Fate Therapeutics Inc. in custom built stock radarsRisk Management & Weekly Top Performers Watchlists - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What is Fate Therapeutics Inc.’s valuation compared to sectorMarket Activity Report & Fast Entry Momentum Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 01:36:52 - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Fate Therapeutics Inc. stock trend forecastEarnings Summary Report & Community Driven Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Understanding Fate Therapeutics Inc.’s price movementMarket Movement Recap & Real-Time Buy Zone Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to interpret RSI for Fate Therapeutics Inc. stockLong Setup & Advanced Technical Analysis Signals - Newser

Aug 31, 2025

Fate Therapeutics Inc (FATE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
大文字化:     |  ボリューム (24 時間):